Key result
C-reactive protein (CRP) levels may play an important role in gauging an individual's risk for a cardiac event and guiding pharmacologic intervention.
CRP measurement may augment current tools for cardiac risk assessment and guide pharmacologic intervention, though it is not currently recommended for mass screening.
CRP may refine targeted risk assessment; leaves open routine use or therapy guidance without prospective trials.
Current theories of atherosclerotic plaque formation suggest that inflammation plays a key role in coronary heart disease. In an effort to augment current tools for cardiac risk assessment, researchers have found that levels of the inflammatory marker C-reactive protein (CRP) may play an important role in gauging an individual's risk for a cardiac event. While not currently recommended for mass population screening, measurement of CRP may play an increasing part in identifying at-risk patients and guiding pharmacologic intervention.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2006) conducted a review in Coronary heart disease. C-reactive protein (CRP) was evaluated. C-reactive protein (CRP) levels may play an important role in gauging an individual's risk for a cardiac event and guiding pharmacologic intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: